Published online June 4, 2007
doi:10.1083/jcb.200612058
The Journal of Cell Biology, Vol. 177, No. 5, 927-939
The Rockefeller University Press, 0021-9525 $30.00
© 2007 Madsen et al.
uPAR-induced cell adhesion and migration: vitronectin provides the key
Chris D. Madsen1,
Gian Maria Sarra Ferraris1,
Annapaola Andolfo1,
Orla Cunningham1, and
Nicolai Sidenius1,2
1 FIRC Institute of Molecular Oncology (IFOM), 20139 Milan, Italy
2 Molecular Genetics Unit, DIBIT, Università Vita-Salute San Raffaele, 20132 Milan, Italy
Correspondence to Nicolai Sidenius: nicolai.sidenius{at}ifom-ieo-campus.it
Expression of the membrane receptor uPAR induces profound changes in cell morphology and migration, and its expression correlates with the malignant phenotype of cancers. To identify the molecular interactions essential for uPAR function in these processes, we carried out a complete functional alanine scan of uPAR in HEK293 cells. Of the 255 mutant receptors characterized, 34 failed to induce changes in cell morphology. Remarkably, the molecular defect of all of these mutants was a specific reduction in integrin-independent cell binding to vitronectin. A membrane-tethered plasminogen activator inhibitor-1, which has the same binding site in vitronectin as uPAR, replicated uPAR-induced changes. A direct uPARvitronectin interaction is thus both required and sufficient to initiate downstream changes in cell morphology, migration, and signal transduction. Collectively these data demonstrate a novel mechanism by which a cell adhesion molecule lacking inherent signaling capability evokes complex cellular responses by modulating the contact between the cell and the matrix without the requirement for direct lateral proteinprotein interactions.
Abbreviations used in this paper: GPI; glycosylphosphatidylinositol, PAI-1, plasminogen activator inhibitor-1; SMB, somatomedin-B domain; uPA, urokinase plasminogen activator; uPAR, urokinase plasminogen activator receptor; Vn, vitronectin.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
uPAR's signaling two step
- Mitch Leslie
J. Cell Biol. 2007 177: 744.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Zhu, S., Gladson, C. L., White, K. E., Ding, Q., Stewart, J. Jr., Jin, T. H., Chapman, H. A. Jr., Olman, M. A.
(2009). Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins. Am. J. Physiol. Lung Cell. Mol. Physiol.
297: L97-L108
[Abstract]
[Full Text]
-
Jo, M., Takimoto, S., Montel, V., Gonias, S. L.
(2009). The Urokinase Receptor Promotes Cancer Metastasis Independently of Urokinase-Type Plasminogen Activator in Mice. Am. J. Pathol.
175: 190-200
[Abstract]
[Full Text]
-
D'mello, V., Singh, S., Wu, Y., Birge, R. B.
(2009). The Urokinase Plasminogen Activator Receptor Promotes Efferocytosis of Apoptotic Cells. J. Biol. Chem.
284: 17030-17038
[Abstract]
[Full Text]
-
Adair, J. E., Stober, V., Sobhany, M., Zhuo, L., Roberts, J. D., Negishi, M., Kimata, K., Garantziotis, S.
(2009). Inter-{alpha}-trypsin Inhibitor Promotes Bronchial Epithelial Repair after Injury through Vitronectin Binding. J. Biol. Chem.
284: 16922-16930
[Abstract]
[Full Text]
-
Alfano, M., Mariani, S. A., Elia, C., Pardi, R., Blasi, F., Poli, G.
(2009). Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells. Blood
113: 1699-1709
[Abstract]
[Full Text]
-
Schiller, H. B., Szekeres, A., Binder, B. R., Stockinger, H., Leksa, V.
(2009). Mannose 6-Phosphate/Insulin-like Growth Factor 2 Receptor Limits Cell Invasion by Controlling {alpha}V{beta}3 Integrin Expression and Proteolytic Processing of Urokinase-type Plasminogen Activator Receptor. Mol. Biol. Cell
20: 745-756
[Abstract]
[Full Text]
-
D'Alessio, S., Gerasi, L., Blasi, F.
(2008). uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro. J. Cell Sci.
121: 3922-3932
[Abstract]
[Full Text]
-
Tang, C.-H., Hill, M. L., Brumwell, A. N., Chapman, H. A., Wei, Y.
(2008). Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with {beta}1 integrins. J. Cell Sci.
121: 3747-3756
[Abstract]
[Full Text]
-
Monaghan-Benson, E., Mastick, C. C., McKeown-Longo, P. J.
(2008). A dual role for caveolin-1 in the regulation of fibronectin matrix assembly by uPAR. J. Cell Sci.
121: 3693-3703
[Abstract]
[Full Text]
-
Smith, H. W., Marra, P., Marshall, C. J.
(2008). uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180. JCB
182: 777-790
[Abstract]
[Full Text]
-
Hillig, T., Engelholm, L. H., Ingvarsen, S., Madsen, D. H., Gardsvoll, H., Larsen, J. K., Ploug, M., Dano, K., Kjoller, L., Behrendt, N.
(2008). A Composite Role of Vitronectin and Urokinase in the Modulation of Cell Morphology upon Expression of the Urokinase Receptor. J. Biol. Chem.
283: 15217-15223
[Abstract]
[Full Text]
-
Caiolfa, V. R., Zamai, M., Malengo, G., Andolfo, A., Madsen, C. D., Sutin, J., Digman, M. A., Gratton, E., Blasi, F., Sidenius, N.
(2007). Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies. JCB
179: 1067-1082
[Abstract]
[Full Text]
-
Elia, C., Cassol, E., Sidenius, N., Blasi, F., Castagna, A., Poli, G., Alfano, M.
(2007). Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. J. Leukoc. Biol.
82: 1212-1220
[Abstract]
[Full Text]